1 |
Radoshitzky SR, Dong L, Chi X, Clester JC, Retterer C, Spurgers K, et al. 2010. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 84: 10569-10580.
DOI
|
2 |
Sadler HA, Stenglein MD, Harris RS, Mansky LM. 2010. APOBEC3G contributes to HIV-1 variation through sublethal mutagenesis. J. Virol. 84: 7396-7404.
DOI
|
3 |
Sanchez-Martinez S, Aloia AL, Harvin D, Mirro J, Gorelick RJ, Jern P, et al. 2012. Studies on the restriction of murine leukemia viruses by mouse APOBEC3. PLoS One 7: e38190.
DOI
|
4 |
Takeuchi Y, Patience C, Magre S, Weiss RA, Banerjee PT, Le Tissier P, Stoye JP. 1998. Host range and interference studies of three classes of pig endogenous retrovirus. J. Virol. 72: 9986-9991.
|
5 |
Tortorec AL, Willey S, Neil SJ. 2011. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3: 520-540.
DOI
|
6 |
Wood A, Webb BLJ, Bartosch B, Schaller T, Takeuchi Y, Towers GJ. 2009. Porcine endogenous retroviruses PERV A and A/C recombinant are insensitive to a range of divergent mammalian TRIM5 proteins including human TRIM5 . J. Gen. Virol. 90: 702-709.
DOI
|
7 |
Zennou V, Bieniasz PD. 2006. Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates. Virology 349: 31-40.
DOI
|
8 |
Zhang J, Liang C. 2010. BST-2 diminishes HIV-1 infectivity. J. Virol. 84: 12336-12343.
DOI
|
9 |
Liberatore RA, Bieniasz PD. 2012. Tetherin is a key effector of the antiretroviral activity of type 1 interferon in vitro and in vivo. Proc. Natl. Acad. Sci. USA 108: 18097-18101.
|
10 |
Magre S, Takeuchi Y, Bartosch B. 2003. Xenotransplantation and pig endogenous retroviruses. Rev. Med. Virol. 13: 311-329.
DOI
ScienceOn
|
11 |
Mattiuzzo G, Ivol S, Takeuchi Y. 2010. Regulation of porcine endogenous retrovirus release by porcine and human tetherins. J. Virol. 84: 2618-2622.
DOI
|
12 |
Miyagi E, Brown CR, Opi S, Khan M, Goila-Gaur R, Kao S, et al. 2010. Stably expressed APOBEC3F has negligible antiviral activity. J. Virol. 84: 11067-11075
DOI
|
13 |
Nakayama EE, Shioda T. 2010. Anti-retroviral activity of TRIM5 . Rev. Med. Virol. 20: 77-92.
DOI
|
14 |
Patience C, Takeuchi Y, Weiss RA. 1997. Infection of human cells by an endogenous retrovirus of pigs. Nat. Med. 3: 282-286.
DOI
ScienceOn
|
15 |
Dorrschuck E, Fischer N, Bravo IG, Hanschmann KM, Kuiper H, Spotter A, et al. 2011. Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases. J. Virol. 85: 3842-3857.
DOI
|
16 |
Dorrschuck E, Munk C, Tonjes RR. 2008. APOBEC3 proteins and porcine endogenous retroviruses. Transplant. Proc. 40: 959-961.
DOI
|
17 |
Fiebig U, Stephan O, Kurth R, Denner J. 2003. Neutralizing antibodies against conserved domains of p15E of porcine endogenous retroviruses: basis for a vaccine for xenotransplantation? Virology 307: 406-413.
DOI
|
18 |
Goila-Gaur R, Strebel K. 2008. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 5: 51.
DOI
|
19 |
Harris RS, Liddament MT. 2004. Retroviral restriction by APOBEC proteins. Nature 4: 868-877.
|
20 |
Jonsson SR, LaRue RS, Stenglein MD, Fahrenkrug SC, Andresdottir V, Harris RS. 2007. The restriction of zoonotic PERV transmission by human APOBEC3G. PLoS One 2:e893.
DOI
|
21 |
Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. 2009. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc. Natl. Acad. Sci. USA 106: 2886-2891.
DOI
|
22 |
Langlois MA, Kemmerich K, Rada C, Neuberger MS. 2009. The AKV murine leukemia virus is restricted and hypermutated by mouse APOBEC3. J. Virol. 83: 11550-11559.
DOI
|
23 |
Le Tortorec A, Willey S, Neil SJ. 2011. Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction. Viruses 3: 520-540.
DOI
|
24 |
Boneva RS, Folks TM, Chapman LE. 2001. Infectious disease issues in xenotransplatation. Clin. Microbiol. Rev. 14: 1-14.
DOI
ScienceOn
|
25 |
Dey A, Mantri CK, Jui PD, Liu B, Pratap S, Dash C. 2011. Downregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells. Virol. J. 8: 531.
DOI
|
26 |
Dieckhoff B, Karlas A, Hofmann A, Kues WA, Petersen B, Pfeifer A, et al. 2007. Inhibition of porcine endogenous retroviruses (PERVs) in primary porcine cells by RNA interference using lentiviral vectors. Arch. Virol. 152: 629-634.
DOI
ScienceOn
|
27 |
Stieler K, Fischer N. 2010. APOBEC3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV. PLoS One 5: e11738.
DOI
|
28 |
Qari SH, Magre S, Garcia-Lerma JG, Hussain AI, Takeuchi Y, Patience C, et al. 2001. Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. J. Virol. 75: 1048-1053.
DOI
|
29 |
Holmes RK, Malim MH, Bishop KN. 2007. APOBECmediated viral restriction: not simply editing? Trends Biochem. Sci. 32: 118-128.
DOI
|